Revive Therapeutics Ltd.
RVVTF
$0.01
$0.00-9.09%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.80M | -7.95M | -2.90M | -3.88M | -4.19M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 100.00 | 200.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.03M | 6.97M | 1.78M | 1.82M | 1.84M |
| Change in Net Operating Assets | 462.50K | 424.10K | 368.70K | 150.30K | -59.60K |
| Cash from Operations | -314.70K | -555.90K | -753.50K | -1.92M | -2.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -22.00K | 7.20K | -22.50K | -22.50K |
| Cash from Investing | 0.00 | -22.00K | 7.20K | -22.50K | -22.50K |
| Total Debt Issued | 65.00K | 65.00K | 65.00K | -- | -- |
| Total Debt Repaid | 0.00 | -25.80K | -104.60K | -143.40K | -182.20K |
| Issuance of Common Stock | 148.80K | -- | 84.10K | 2.10M | 2.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.80K | 0.00 | -19.50K | 19.30K | 58.10K |
| Cash from Financing | 134.60K | 26.60K | 16.10K | 1.47M | 1.47M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.10K | -551.30K | -730.20K | -471.00K | -964.90K |